SciELO - Scientific Electronic Library Online

 
vol.148 número10¿Aprender Medicina a distancia?: percepción de estudiantes confinados por la pandemia COVID-19Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad? índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

SAMANIEGO, Francisco  y  CONTE, Guillermo. SARS-CoV-2 infection as a thrombo-inflammatory endothelial disease. Rev. méd. Chile [online]. 2020, vol.148, n.10, pp.1467-1474. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872020001001467.

Coronavirus disease 19 is characterized by an intense inflammatory response and a high incidence of thrombotic events. Autopsy studies show severe endothelial injury associated with thrombosis of the alveolar capillaries of the lungs and other organs. In the pathophysiology of this disease endothelial injury and dysfunction, inflammation and thrombosis are key factors for the development of severe phenotypes. Therefore, we should consider this entity as a systemic endothelial disease in which an obstructive microvascular syndrome secondary to an intense thrombo-inflammatory response leads to acute respiratory insufficiency and multiorgan failure. Heparin is an excellent drug to treat Covid-19 patients due to its anticoagulant, anti-inflammatory, antiviral and endothelial effects. Clinical guidelines agree that the use of heparin thromboprophylaxis is a component of Covid-19 coagulopathy treatment, even though the dose and duration of treatments are not well defined.

Palabras clave : Coronavirus; Disseminated Intravascular Coagulation; Thrombosis.

        · texto en Español     · Español ( pdf )